Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The conversion of testosterone into dihydrotestosterone by steroid 5 alpha-reductase is a key reaction in androgen action, and is essential both for the formation of the male phenotype during embryogenesis and for androgen-mediated growth of tissues such as the prostate. Single gene defects that impair this conversion lead to pseudohermaphroditism in which 46X,Y males have male internal urogenital tracts, but female external genitalia. We have described the isolation of a human 5 alpha-reductase complementary DNA from prostate. Subsequent cloning and genetic studies showed that this gene (designated 5 alpha-reductase 1) was normal in patients with 5 alpha-reductase deficiency. We report here the isolation of a second 5 alpha-reductase cDNA by expression cloning and the polymerase chain reaction. The biochemical and pharmacological properties of this cDNA-encoded enzyme (designated 5 alpha-reductase 2) are consistent with it being the major isozyme in genital tissue. A deletion in this gene is present in two related individuals with male pseudohermaphroditism caused by 5 alpha-reductase deficiency. These results verify the existence of at least two 5 alpha-reductases in man and provide insight into a fundamental hormone-mediated event in male sexual differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgens and in particular the intraprostatic conversion of circulating T to DHT by SRD5A2 (Russell and Wilson, 1994) are required for normal prostate development and function (Andersson et al., 1991, Imperato-McGinley et al., 1974).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Andersson et al., 1991
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Shinozaki, K., Ohme, M., Tanaka, M., Wakasugi, T., Hayashida, N., Matsubayashi, T., Zaita, N., Chunwongse, J., Obokata, J., Yamaguchi-Shinozaki, K., et al. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04464.x · Cited by 2,403
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Self-citationA regulatory hierarchy for cell specialization in yeast
Herskowitz, I. (1989) · Nature · doi:10.1038/342749a0 · Cited by 590
Research works printed but not linked: 4
- Wilson, J. D. Harvey Lect. 79, 145–172 (1985).
- Wilson, J. D. Endocrinology 25, 491–508 (1975).
- Gorman, C. M., Gies, D. R. & McCray, G. DNA Prot. Engng. Tech. 2, 3–10 (1990).
- Jenkins, E. P., Andersson, S., Imperato-McGinley, J., Wilson, J. D. & Russell, D. W. J. clin. Invest. (in the press).
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Neurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., & Russell, D. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116665 · Cited by 727
Self-citationValidating therapeutic targets through human genetics
Plenge, R. M., Scolnick, E. M., & Altshuler, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4051 · Cited by 712
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa
Otto, B., Cuntz, U., Fruehauf, E., Wawarta, R., Folwaczny, C., Riepl, R., Heiman, M., Lehnert, P., Fichter, M., & Tschop, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje-1450669 · Cited by 689
“In humans, two isozymes of 5a-reductase, which differ in tissue distribution and biochemical characteristics as well as in their responsiveness to specific inhibitors of their enzymatic activity, have been identified (42, 43 ).”
BackgroundHazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., Davoine, C.-S., Cruaud, C., Dürr, A., Wincker, P., et al. (1999) · Nature Genetics · doi:10.1038/15472 · Cited by 634
Genetic dissection of mammalian fertility pathways
Matzuk, M. M., & Lamb, D. J. (2002) · Nature Cell Biology · doi:10.1038/ncb-nm-fertilitys41 · Cited by 579
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
Self-citationSteroid 5α-reductase 2 deficiency
Mendonca, B. B., Batista, R. L., Domenice, S., Costa, E. M. F., Arnhold, I. J. P., Russell, D. W., & Wilson, J. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.020 · Cited by 546
Self-citationNeurosteroid metabolism in the human brain
Stoffel-Wagner, B. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450669 · Cited by 538
“In humans, two isozymes of 5 a -reductase, which differ in tissue distribution and biochemical characteristics as well as in their responsiveness to specific inhibitors of their enzymatic activity, have been identified (42, 43).”
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
“This gene is not responsible for 5 -reductase deficiency and is relatively insensitive to the inhibitor finasteride (136).”
BackgroundSawaya, M. E., & Price, V. H. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12335779 · Cited by 505
Hormonal, cellular, and molecular control of prostatic development
Marker, P. C., Donjacour, A. A., Dahiya, R., & Cunha, G. R. (2003) · Developmental Biology · doi:10.1016/s0012-1606(02)00031-3 · Cited by 469
Sex Determination and Differentiation
MacLaughlin, D. T., & Donahoe, P. K. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022784 · Cited by 454
Role of Hormones in Pilosebaceous Unit Development
Deplewski, D., & Rosenfield, R. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.4.0404 · Cited by 443
“The type 2 isozyme is important for most androgen actions in sexual organs (123), and a deficiency of 5a-reductase type 2 in humans is a cause of male pseudohermaphroditism (115, 124).”
BackgroundAndrogen Signaling in Prostate Cancer
Dai, C., Heemers, H., & Sharifi, N. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030452 · Cited by 406
“A loss-of-function mutation in SRD5A2 causes 5a-reductase deficiency, manifesting in pseudohermaphroditism and failure to develop a normal prostate (Imperato-McGinley et al. 1974; Andersson et al. 1991).”
BackgroundThe Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque-Ramírez, M., & San Millán, J. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 422
“Mutations in SRD5A2 result in male pseudohermaphroditism (190, 191).”
BackgroundMolecular genetics of steroid 5 alpha-reductase 2 deficiency
Thigpen, A. E., Davis, D. L., Milatovich, A., Mendonca, B. B., Imperato-McGinley, J., Griffin, J. E., Francke, U., Wilson, J. D., & Russell, D. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115954 · Cited by 422
Self-citationAdvancing human genetics research and drug discovery through exome sequencing of the UK Biobank
Szustakowski, J. D., Balasubramanian, S., Kvikstad, E., Khalid, S., Bronson, P. G., Sasson, A., Wong, E., Liu, D., Wade Davis, J., Haefliger, C., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00885-0 · Cited by 401
Mensah-Nyagan, A. G., Do-Rego, J.-L., Beaujean, D., Luu-The, V., Pelletier, G., & Vaudry, H. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01395-4 · Cited by 379
“R have been cloned from a prostate library; these cDNAs exhibit an overall sequence identity of 60% (Andersson and Russell, 1990; Andersson et al., 1991).”
Normington, K., & Russell, D. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41809-1 · Cited by 379
Self-citationLabrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
Chang, K.-H., Li, R., Papari-Zareei, M., Watumull, L., Zhao, Y. D., Auchus, R. J., & Sharifi, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107898108 · Cited by 346
“This “conventional” pathway (AD→T→DHT) in CRPC has been generally surmised by genetic deficiencies in enzymes required to convert AD to T in the testes (17) and T to DHT in the normal prostate (18), and furthermore implies the requirement for T as an obligate precursor of DHT.”
BackgroundSteroid 5α-Reductase 2 Deficiency*
WILSON, J. D., GRIFFIN, J. E., & RUSSELL, D. W. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-577 · Cited by 346
Self-citationOlsen, E. A. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117426 · Cited by 305
Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
Imperato-McGinley, J., & Zhu, Y.-S. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00368-4 · Cited by 306
Cantagrel, V., Lefeber, D. J., Ng, B. G., Guan, Z., Silhavy, J. L., Bielas, S. L., Lehle, L., Hombauer, H., Adamowicz, M., Swiezewska, E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.001 · Cited by 309
“…of the SRD5A2 gene in human causes male pseudohermaphroditism as a result of an enzymatic block of testosterone to dihydrotestosterone conversion (Andersson et al., 1991), and mutation of the Srd5a1 gene in mice affects reproduction and parturition, suggesting involvement in androgen metabolism…”
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
Price, V. H., Roberts, J. L., Hordinsky, M., Olsen, E. A., Savin, R., Bergfeld, W., Fiedler, V., Lucky, A., Whiting, D. A., Pappas, F., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107953 · Cited by 296
Traish, A. M., Hassani, J., Guay, A. T., Zitzmann, M., & Hansen, M. L. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02157.x · Cited by 275
DHEA and peripheral androgen and estrogen formation: intracrinology
LABRIE, F., BÉLANGER, A., SIMARD, J., LUU‐THE, V., & LABRIE, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17369.x · Cited by 280
Evaluation and treatment of male and female pattern hair loss
Olsen, E. A., Messenger, A. G., Shapiro, J., Bergfeld, W. F., Hordinsky, M. K., Roberts, J. L., Stough, D., Washenik, K., & Whiting, D. A. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.008 · Cited by 280
Cutaneous androgen metabolism: basic research and clinical perspectives
Chen, W., Thiboutot, D., & Zouboulis, C. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00613.x · Cited by 273
“Over the last decade, molecular cloning studies have characterized two genes that encode two isoenzymes of 5a-reductase, namely, type 1 and type 2; the former exists predominantly in the skin, whereas the latter in the prostate (Andersson and Russell, 1990; Andersson et al, 1991).”
BackgroundBrassinosteroid control of sex determination in maize
Hartwig, T., Chuck, G. S., Fujioka, S., Klempien, A., Weizbauer, R., Potluri, D. P. V., Choe, S., Johal, G. S., & Schulz, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108359108 · Cited by 265
“The human ortholog of DET2—steroid 5α-reductase 2—is required for male sex differentiation because its deficiency causes genetic males to develop as pseudohermaphrodites with feminized organs (31).”
BackgroundNeuroactive steroids: State of the art and new perspectives
Melcangi, R. C., Garcia-Segura, L. M., & Mensah-Nyagan, A. G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7403-5 · Cited by 233
Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase
Luu-The, V. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00155-2 · Cited by 247
Imperato‐McGinley, J., Sanchez, R. S., Spencer, J. R., Yee, B., & Vaughan, E. D. (1992) · Endocrinology · doi:10.1210/en.131.3.1149 · Cited by 245
Identification of androgen receptor protein and 5alpha -reductase mRNA in human ocular tissues
Rocha, E. M. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.1.76 · Cited by 238
Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
Bartsch, G., Rittmaster, R. S., & Klocker, H. (2000) · European Urology · doi:10.1159/000020181 · Cited by 238
“], who have identified two genes that encode the isoenzymes termed 5a–reductase type 1 and type 2. Both isotypes have high contents of hydrophobic amino acids and very similar hydrophobicity patterns although their amino acid sequence homology is only about 50p. Due to their high lipophilicity, they are associated wit…”
BackgroundInfluentialWood, A. J. J., & Rittmaster, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401133300208 · Cited by 240
Rhéaume, E., Simard, J., Morel, Y., Mebarki, F., Zachmann, M., Forest, M. G., New, M. I., & Labrie, F. (1992) · Nature Genetics · doi:10.1038/ng0792-239 · Cited by 235
THE PROSTATE: DEVELOPMENT AND PHYSIOLOGY
Hayward, S. W., & Cunha, G. R. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70146-9 · Cited by 216
An overview on 5α-reductase inhibitors
Aggarwal, S., Thareja, S., Verma, A., Bhardwaj, T. R., & Kumar, M. (2010) · Steroids · doi:10.1016/j.steroids.2009.10.005 · Cited by 223
Androgen Resistance — The Clinical and Molecular Spectrum
Flier, J. S., Underhill, L. H., & Griffin, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260906 · Cited by 220
Structure–activity relationships for inhibition of human 5α-reductases by polyphenols
Hiipakka, R. A., Zhang, H.-Z., Dai, W., Dai, Q., & Liao, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00848-1 · Cited by 216
Maimoun, L., Philibert, P., Cammas, B., Audran, F., Bouchard, P., Fenichel, P., Cartigny, M., Pienkowski, C., Polak, M., Skordis, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1024 · Cited by 216
Androgenetic alopecia and microinflammation
Mahé, Y. F., Michelet, J., Billoni, N., Jarrousse, F., BTS, Buan, B., BTS, Commo, S., BTS, Saint‐Léger, D., et al. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00612.x · Cited by 214
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
Thiboutot, D., Harris, G., Iles, V., Cimis, G., Gilliland, K., & Hagari, S. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317162 · Cited by 221
Imperato-McGinley, J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.524 · Cited by 219
Biosynthesis of neurosteroids and regulation of their sysnthesis
Mellon, S. H., & Vaudry, H. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46058-2 · Cited by 215
Basic concepts and recent developments in human steroid hormone biosynthesis
Ghayee, H. K., & Auchus, R. J. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9052-2 · Cited by 212
“It is unlikely that the backdoor pathway is involved in the formation of the male external genitalia during normal human development because mutations in 5αreductase type 2 are sufficient to cause severe male pseudohermaphroditism [ 56 ].”
BackgroundEstrogen and androgen signaling in the pathogenesis of BPH
Ho, C. K. M., & Habib, F. K. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2010.207 · Cited by 209
“5α-Reductase Two distinct isozymes of 5α-reductase—type 1 (5αR1) and type 2 (5αR2)—have been identified in humans”
Dallob, A. L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.703 · Cited by 208
Androgen actions on the human hair follicle: perspectives
Inui, S., & Itami, S. (2013) · Experimental Dermatology · doi:10.1111/exd.12024 · Cited by 195
Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications
STOFFEL‐WAGNER, B. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.007 · Cited by 195
Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle
Sato, K., Iemitsu, M., Aizawa, K., & Ajisaka, R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00678.2007 · Cited by 190
“8 (31), 17β-HSD type 1 (12), 5α-reductase type 1 (11), type 2 (3) and beta-actin (25).”
Inhibitors of Testosterone Biosynthetic and Metabolic Activation Enzymes
Ye, L., Su, Z.-J., & Ge, R.-S. (2011) · Molecules · doi:10.3390/molecules16129983 · Cited by 189
A New Look at the 5?-Reductase Inhibitor Finasteride
Finn, D. A., Beadles-Bohling, A. S., Beckley, E. H., Ford, M. M., Gililland, K. R., Gorin-Meyer, R. E., & Wiren, K. M. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00053.x · Cited by 179
ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
Kaufman, K. D. (1996) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70396-x · Cited by 187
Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome
Pankau, R., Partsch, C., Winter, M., Gosch, A., & Wessel, A. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960503)63:1<243::aid-ajmg42>3.0.co;2-l · Cited by 92
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
Crawford, E. D. (2009) · Urology · doi:10.1016/j.urology.2009.03.001 · Cited by 174
Finasteride: A Review of its Use in Male Pattern Hair Loss
McClellan, K. J., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199957010-00014 · Cited by 171
Natural Mutagenesis Study of the Human Steroid 5.alpha.-Reductase 2 Isoenzyme
Wigley, W. C., Prihoda, J. S., Mowszowicz, I., Mendonca, B. B., New, M. I., Wilson, J. D., & Russell, D. W. (1994) · Biochemistry · doi:10.1021/bi00171a029 · Cited by 174
Self-citationLuu-The, V., Tremblay, P., & Labrie, F. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0058 · Cited by 173
Androgen Metabolism in Sebaceous Glands From Subjects With and Without Acne
Thiboutot, D., Gilliland, K., Light, J., & Lookingbill, D. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.9.1041 · Cited by 169
Androgen biosynthetic pathways in the human prostate
Luu-The, V., Bélanger, A., & Labrie, F. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.01.008 · Cited by 169
Conservation of function between mammalian and plant steroid 5α-reductases
Li, J., Biswas, M. G., Chao, A., Russell, D. W., & Chory, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3554 · Cited by 167
Self-citationPharmacological Options in the Treatment of Benign Prostatic Hyperplasia
Kenny, B., Ballard, S., Blagg, J., & Fox, D. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960697s · Cited by 169
Human gene mutations causing infertility
Layman, L. C. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.153 · Cited by 164
Assessment of steroidogenesis and steroidogenic enzyme functions
Luu-The, V. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.017 · Cited by 160
Bull, H. G., Garcia-Calvo, M., Andersson, S., Baginsky, W. F., Chan, H. K., Ellsworth, D. E., Miller, R. R., Stearns, R. A., Bakshi, R. K., Rasmusson, G. H., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja953069t · Cited by 157
Self-citationDevelopment of the human prostate
Cunha, G. R., Vezina, C. M., Isaacson, D. S., Ricke, W. A., Timms, B. G., Cao, M., Franco, O. E., & Baskin, L. S. (2018) · Differentiation · doi:10.1016/j.diff.2018.08.005 · Cited by 169
“Early reports of human prostatic development are mostly based upon histologic studies published decades ago (Lowsley, 1912; Glenister, 1962; Andrews, 1951; Brody and Goldman, 1940).”
Physical Activity and Benign Prostatic Hyperplasia
Platz, E. A., Kawachi, I., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.21.2349 · Cited by 155
“Prostatic epithelial cell proliferation is influenced by androgens, as evidenced by androgen receptor expression in prostatic epithelium,(27,28) reduction in hyperplastic prostate mass (primarily of the epithelium) with androgen deprivation,(29) the absence of BPH in men who are castrated before puberty,(30) and the s…”
BackgroundWessells, H., Roy, J., Bannow, J., Grayhack, J. T., Matsumoto, A. M., Tenover, J. L., Herlihy, R. E., Fitch, W. P., Labasky, R. F., Auerbach, S., et al. (2003) · Urology · doi:10.1016/s0090-4295(02)02401-9 · Cited by 163
Hubert, F., Kinkel, S., Crewther, P. E., Cannon, P., Webster, K. E., Link, M., Uibo, R., O’Bryan, M. K., Meager, A., Forehan, S. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802124 · Cited by 151
“58) or as a consequence of the immunoneutralization of major components of the steroidogenic pathway, for example,17HSBD3 (59) and SRD5A2 (60).”
BackgroundRole of Androgens in Prostatic Cancer
Isaacs, J. T. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61152-8 · Cited by 179
Disorders of sex development (DSDs), their presentation and management in different cultures
Warne, G. L., & Raza, J. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9084-2 · Cited by 149
“It is also prevalent in southern Lebanon [23], the Eastern Highlands Province of Papua-New Guinea [ 24 ] but is relatively rare in the Caucasian race.”
BackgroundThe Intracrine Sex Steroid Biosynthesis Pathways
Luu-The, V., & Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81010-2 · Cited by 167
Molecular Mechanisms of Androgen Action
Lindzey, J. K., Kumar, M. V., Grossman, M., Young, C. Y. F., & Tindall, D. J. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61151-6 · Cited by 176
Alcohol Consumption, Cigarette Smoking, and Risk of Benign Prostatic Hyperplasia
Platz, E. A., Rimm, E. B., Kawachi, I. I., Colditz, G. A., Stampfer, M. J., Willett, W. C., & Giovannucci, E. L. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009775 · Cited by 161
“Androgens play a role in the development and maintenance of BPH particularly in the prostatic epithelium, which is supported by androgen receptor expression in prostatic epithelium (34, 35), reduction in hyperplastic prostate mass, primarily of the epithelium, with androgen deprivation (36), and the absence of BPH in…”
BackgroundGene Expression in the Epididymis
Kirchhoff, C. (1999) · International review of cytology · doi:10.1016/s0074-7696(08)61567-3 · Cited by 159
Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling
Pihlajamaa, P., Sahu, B., & Jänne, O. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1034 · Cited by 141
El-Alfy, M., Luu-The, V., Huang, X.-F., Berger, L., Labrie, F., & Pelletier, G. (1999) · Endocrinology · doi:10.1210/endo.140.3.6585 · Cited by 136
Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors
Iehlé, C., Délos, S., Guirou, O., Tate, R. J., Raynaud, J., & Martin, P. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00134-l · Cited by 141
Mendonca, B. B., Inacio, M., Costa, E. M. F., Arnhold, I. J. P., Silva, F. A. Q., Nicolau, W., Bloise, W., Russell, D. W., & Wilson, J. D. (1996) · Medicine · doi:10.1097/00005792-199603000-00003 · Cited by 143
Self-citationBiological Esterification of Steroids*
Hochberg, R. B. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0330 · Cited by 138
“For example, there are at least two forms of the 11b-dehydrogenase (72, 73) and 5a-reductase (74, 75) enzymes, and the higher affinity enzymes are extremely important in regulating the action of corticoids and androgens, respectively.”
BackgroundLabrie, F., Luu-The, V., Labrie, C., Pelletier, G., & El-Alfy, M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053264 · Cited by 128
Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp.
Harris, G., Azzolina, B., Baginsky, W., Cimis, G., Rasmusson, G. H., Tolman, R. L., Raetz, C. R., & Ellsworth, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10787 · Cited by 130
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
Bartsch, G., Rittmaster, R., & Klocker, H. (2002) · World Journal of Urology · doi:10.1007/s00345-002-0248-5 · Cited by 128
“The virilisation of the external genitalia is dependent on the conversion of testosterone to dihydrotestosterone in the tissues of the urogenital sinus, and a deficiency in type 2 5a-reductase activity leads to an incomplete form of male pseudohermaphroditism [ 5 , 46, 99, 106] (Fig. 1a, b). Affected males undergo var…”
BackgroundAndrogen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“The syndrome of 5αreductase deficiency, a disorder of male sexual differentiation, is due to mutations in the gene encoding the type 2 enzyme [ 128 ].”
BackgroundRhodes, L., Primka, R. L., Berman, C., Vergult, G., Gabriel, M., Malice, M., & Gibelin, B. (1993) · The Prostate · doi:10.1002/pros.2990220107 · Cited by 127
Zebrafish Androgen Receptor: Isolation, Molecular, and Biochemical Characterization1
Hossain, M. S., Larsson, A. O., Scherbak, N. N., Olsson, P., & Orbán, L. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.062018 · Cited by 137
Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia
Suzuki, S., Platz, E. A., Kawachi, I. I., Willett, W. C., & Giovannucci, E. L. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.689 · Cited by 125
Iehlé, C., Radvanyi, F., de Medina, S. G. D., Ouafik, L., Gérard, H., Chopin, D. K., Raynaud, J., & Martin, P. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00030-8 · Cited by 123
Plosker, G. L., & Brogden, R. N. (1996) · Drugs & Aging · doi:10.2165/00002512-199609050-00008 · Cited by 123
Molecular genetic cascades for external genitalia formation: An emerging organogenesis program
Yamada, G., Suzuki, K., Haraguchi, R., Miyagawa, S., Satoh, Y., Kamimura, M., Nakagata, N., Kataoka, H., Kuroiwa, A., & Chen, Y. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20807 · Cited by 126
“Mutations in androgen receptor gene (Murakami, 1987; Yeh et al., 2002; Sato et al., 2003) or for androgen synthetic enzymes (Andersson et al., 1991; Wilson, 1992) result in abnormalities in male sexual differentiation and development.”
BackgroundMolecular epidemiology of hypospadias: Review of genetic and environmental risk factors
Manson, J. M., & Carr, M. C. (2003) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.10084 · Cited by 129
“The gene for SRD5A1 is located on the short arm of chromosome 5 (5p15), and is normal in male pseudohermaphrodites (Andersson et al., 1991; Thigpen et al., 1992).”
BackgroundAndrogen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I
Horton, R. (1993) · Endocrinology · doi:10.1210/en.133.2.447 · Cited by 121
Metadata
- Authors
- Andersson, S., Berman, D. M., Jenkins, E. P., & Russell, D. W.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1991-11
- Volume
- 354
- Issue
- 6349
- Pages
- 159-161
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4451825
- OpenAlex
- W2058387263
- Cited by
- 643
- References
- 29
- Citations by year
- 2026: 9 · 2025: 3 · 2024: 6 · 2023: 13 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 13 · 2012: 15
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL020948)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- 5-alpha-reductase deficiency, 46,XY disorders of sex development, dihydrotestosterone, androgen action, male sexual differentiation, gene deletion, cDNA cloning, isozymes, prostate
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Genes, Humans, Hydrogen-Ion Concentration, Isoenzymes, Molecular Sequence Data, Disorders of Sex Development, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Blotting, Southern, Sequence Alignment, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.